Canadian Cannabis Company Adastra Gets Permission To Sell Cocaine 

Their license was amended in February to include cocaine

British Columbia-based cannabis company Adastra Labs has been approved by Health Canada to possess, produce, sell and distribute cocaine, psilocybin and psilocin.

The company received its Controlled Drug and Substances dealer’s license for the psychedelics in August, according to a news release.

The license was amended in February to include cocaine.

The dealer’s license allows the company to:

  • Possess, produce, sell and distribute – for legal purposes only and not to consumers – up to 250 grams (8.8 ounces) of cocaine and to import and manufacture coca leaves to create synthetics.
  • Possess, produce, sell and distribute up to 1,000 grams of psilocybin and psilocin.

A dealer’s license allows sales for clinical and scientific research or for medical purposes that have been legalized.

British Columbia decriminalized drug possession, effective Jan. 31, to allow adults 18 and older to possess up to 2.5 grams of opioids, cocaine, methamphetamine and MDMA.

Trafficking those drugs remains illegal.

To Read The Rest Of This Article On MJ Biz Daily, Click Here

Stay up-to-date!

Get all the news and info straight into your inbox that you need to help grow your business.

Marijuana Retail Report, is a national daily online trade publication serving retailers of marijuana products and accessories. News and information are geared strictly to select retail channels, with distribution limited to licensed collectives, recreational retailers, accessories retailers, and wholesalers.


Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!

To Top